Peter Crane (@peterkcrane) 's Twitter Profile
Peter Crane

@peterkcrane

ID: 2312367282

linkhttp://www.entelo.bio calendar_today26-01-2014 19:44:25

44 Tweet

1,1K Followers

2,2K Following

Ale Maiano (@ale_maiano) 's Twitter Profile Photo

This time last week the #UK government approved in full a proposal to reform how spinouts work. I have had the privilege to help shape the 11 Recommendations and below I share what each means for #scientists + all stakeholders Recommendation 7! 🫶 wilbe.com/post/our-journ…

This time last week the #UK government approved in full a proposal to reform how spinouts work. 

I have had the privilege to help shape the 11 Recommendations and below I share what each means for #scientists + all stakeholders 

Recommendation 7! 🫶

wilbe.com/post/our-journ…
ian (@ianrountree) 's Twitter Profile Photo

Let me tell you about Phenomic AI, our first investment in AI drug discovery back in 2018. It's called Phenomic because it was initially using computer vision to run phenotypic analysis of potential cancer treatments––think "Recursion for biologics". After layering in single-cell

Alex Colville (@alexjcolville) 's Twitter Profile Photo

For biotech companies started in the last 50 years that were acquired for at least $10B or that trade at market caps of at least $10B, 6 out of the 21 CEOs were between 29 and 35 years old.

For biotech companies started in the last 50 years that were acquired for at least $10B or that trade at market caps of at least $10B, 6 out of the 21 CEOs were between 29 and 35 years old.
Nathan Benaich (@nathanbenaich) 's Twitter Profile Photo

🆕Lobbyists for VC, tech, and life sciences in the UK routinely attribute the challenges start-ups face scaling to “funding gaps”. 🧐At the same time, we hear endless discussions about the volume of dry powder funds have at their disposal. 🧵How can both be true?

🆕Lobbyists for VC, tech, and life sciences in the UK routinely attribute the challenges start-ups face scaling to “funding gaps”.

🧐At the same time, we hear endless discussions about the volume of dry powder funds have at their disposal.

🧵How can both be true?
Peter Crane (@peterkcrane) 's Twitter Profile Photo

Great points from Jamie Macfarlane Vishal Gulati (I back scientists) Michael Bronstein Air Street Capital. Improved + faster spin out deals - AND removing “quasi monopolistic” funding arrangements to bring true competition and choice would be transformative. Already recommended by spinout review…

Jake P. Taylor-King (@wildtypehuman) 's Twitter Profile Photo

Loved working with Adam Cribbs on this! One crucial omission though: if you're in London, every other month our meetings result in a few beers to talk all things #singlecell and #sequencing ;) We're always looking for extras!

Peter Crane (@peterkcrane) 's Twitter Profile Photo

The growth plan announced today is welcome (we all hate driving Cam-Ox). However, it lacks any true reform to empower and encourage founders to start, grow, scale and stay in the UK, and thus won't likely change anything about the prevailing "head west" vibe. What

Anne Carpenter, PhD (@drannecarpenter) 's Twitter Profile Photo

I’d love to hear biologists weigh in on the fundamental question: can you predict the impact of cell perturbations better by studying the natural variation in a population of healthy cells (more data), or by studying cells that have been perturbed genetically or chemically?

Andrew White 🐦‍⬛ (@andrewwhite01) 's Twitter Profile Photo

I finished my estimate on required compute to make an atomic-resolution virtual cell: 10^38 FLOPs to simulate a human cell for 1 day. We should be able to do this simulation in 2074 using 200 TW of power. 1/3

I finished my estimate on required compute to make an atomic-resolution virtual cell: 10^38 FLOPs to simulate a human cell for 1 day. We should be able to do this simulation in 2074 using 200 TW of power. 1/3